TY - JOUR
T1 - Label-free cytotoxicity screening assay by digital holographic microscopy
AU - Kühn, Jonas
AU - Shaffer, Etienne
AU - Mena, Julien
AU - Breton, Billy
AU - Parent, Jérôme
AU - Rappaz, Benjamin
AU - Chambon, Marc
AU - Emery, Yves
AU - Magistretti, Pierre
AU - Depeursinge, Christian
AU - Marquet, Pierre
AU - Turcatti, Gerardo
PY - 2013/3/1
Y1 - 2013/3/1
N2 - We introduce a label-free technology based on digital holographic microscopy (DHM) with applicability for screening by imaging, and we demonstrate its capability for cytotoxicity assessment using mammalian living cells. For this first high content screening compatible application, we automatized a digital holographic microscope for image acquisition of cells using commercially available 96-well plates. Data generated through both label-free DHM imaging and fluorescence-based methods were in good agreement for cell viability identification and a Z′-factor close to 0.9 was determined, validating the robustness of DHM assay for phenotypic screening. Further, an excellent correlation was obtained between experimental cytotoxicity dose-response curves and known IC50 values for different toxic compounds. For comparable results, DHM has the major advantages of being label free and close to an order of magnitude faster than automated standard fluorescence microscopy.
AB - We introduce a label-free technology based on digital holographic microscopy (DHM) with applicability for screening by imaging, and we demonstrate its capability for cytotoxicity assessment using mammalian living cells. For this first high content screening compatible application, we automatized a digital holographic microscope for image acquisition of cells using commercially available 96-well plates. Data generated through both label-free DHM imaging and fluorescence-based methods were in good agreement for cell viability identification and a Z′-factor close to 0.9 was determined, validating the robustness of DHM assay for phenotypic screening. Further, an excellent correlation was obtained between experimental cytotoxicity dose-response curves and known IC50 values for different toxic compounds. For comparable results, DHM has the major advantages of being label free and close to an order of magnitude faster than automated standard fluorescence microscopy.
UR - http://www.scopus.com/inward/record.url?scp=84874834445&partnerID=8YFLogxK
U2 - 10.1089/adt.2012.476
DO - 10.1089/adt.2012.476
M3 - Article
C2 - 23062077
AN - SCOPUS:84874834445
SN - 1540-658X
VL - 11
SP - 101
EP - 107
JO - Assay and Drug Development Technologies
JF - Assay and Drug Development Technologies
IS - 2
ER -